Human tumor immunology at the molecular divide

Journal of Immunology

Volumn 178, Issue 5, 2007, Pages 2615-2616

  Finn, Olivera J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; TUMOR IMMUNOLOGY;

EID: 33847413969     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.5.2615     Document Type: Short Survey

References (16)

1. Barnd, D. L., M. S. Lan, R. S. Metzgar, and O. J. Finn. 1989. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA 86: 7159-7163.
2. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-1647.
3. Prehn, R. T., and J. M. Main. 1957. Immunity to methylcholanthrene- induced sarcomas. Natl Cancer Inst. 18: 769-778.
4. Klein, G., H. O. Sjogren, E. Klein, and K. E. Hellstrom. 1960. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 20: 1561-1572.
5. Vose, B. M., F. Vanky, and E. Klein. 1977. Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans. Int. J. Cancer 20: 512-519.
6. Vanky, F. T., B. M. Vose, M. Fopp, and E. Klein. 1979. Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity. J. Natl. Cancer Inst. 62: 1407-1413.
7. Vose, B. M., F. Vanky, M. Fopp, and E. Klein. 1978. In vitro generation of cytotoxicity against autologous human tumour biopsy cells. Int. J. Cancer 21: 588-593.
8. Vose, B. M., F. Vanky, M. Fopp, and E. Klein. 1978. Restricted autologous lymphocytotoxicity in lung neoplasia. Br. J. Cancer 38: 375-381.
9. Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497.
10. Hellstrom, K. E., J. P. Brown, and I. Hellstrom. 1980. Monoclonal antibodies to tumor antigens. Contemp. Top. Immunobiol. 11: 117-137.
11. Hellstrom, K. E., I. Hellstrom, and J. P. Brown. 1982. Human tumor-associated antigens identified by monoclonal antibodies. Springer Semin. Immunopathol. 5: 127-146.
12. Gillis, S., P. E. Baker, F. W. Ruscetti, and K. A. Smith. 1978. Long-term culture of human antigen-specific cytotoxic T-cell lines. J. Exp. Med. 148:1093-1098.
13. Gillis, S., and K. A. Smith. 1977. Long term culture of tumour-specific cytotoxic T cells. Nature 268: 154-156.
14. Van den Eynde, B., B. Lethe, A. Van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173: 1373-1384.
15. Henderson, R. A., and O. J. Finn. 1996. Human rumor antigens are ready to fly. Adv. Immunol. 62: 217-256.
16. Graziano, D. F., and O. J. Finn. 2005. Tumor antigens and tumor antigen discovery. Cancer Treat. Res. 123: 89-111.